A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021

Clinical trial NCT01121380 · TERMINATED

Trial details

NCT number: NCT01121380
Sponsor: BioLineRx, Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2011-06-01
Primary completion: 2011-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.